| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |